Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this interesting session on Expert group convenes to discuss management strategies for EGFR mutation-positive NSCLC.
The Expert Group meeting on the management of EGFR mutation-positive non-small cell lung cancer (NSCLC) convenes to address critical aspects of treatment strategies, therapeutic advancements, and patient care. Participants, including leading oncologists, researchers, and healthcare professionals, gather to discuss the latest developments in targeted therapies, molecular diagnostics, and personalized medicine for patients with EGFR mutation-positive NSCLC.
The meeting aims to foster collaboration, exchange scientific insights, and explore innovative approaches to optimize patient outcomes and quality of life. Through comprehensive discussions, evidence-based presentations, and case studies, the Expert Group endeavors to refine treatment algorithms, identify emerging challenges, and propose novel solutions to enhance the standard of care for individuals affected by EGFR mutation-positive NSCLC.
Ultimately, the collaborative efforts of the Expert Group contribute to advancing the field of oncology and improving the prognosis and management of EGFR-driven NSCLC.
Therefore, get an overall knowledge on Expert group convenes to discuss management strategies for EGFR mutation-positive NSCLC. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
RML to develop bone marrow transplantation at Lady Hardinge Medical College in Safdarjung
3.
New First-Line Option for Advanced ALK-Positive Lung Cancer
4.
Review looks at potential treatment targets in the tumor microenvironment.
5.
Study finds 10% of pediatric blood cancers may stem from medical imaging radiation
1.
Unlocking the Secrets of Ringed Sideroblasts: A New Frontier in Hematology
2.
Nuclear Medicine's Role in Battling Women's Cancers
3.
Integrative Clinical Genomics of Metastatic Cancer: Decoding Tumor Evolution for Precision Oncology
4.
AI-Powered Rehabilitation: A Game Changer for Hemophilia Management
5.
Symptoms and Causes of Phlegmasia Cerulea Dolens: A Comprehensive Guide
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
2.
Thromboprophylaxis In Medical Settings
3.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
5.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation